These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14524736)

  • 1. Oral fludarabine: a viewpoint by Bruce D. Cheson.
    Cheson BD
    Drugs; 2003; 63(21):2325. PubMed ID: 14524736
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral fludarabine: a viewpoint by Dieter Huhn.
    Huhn D
    Drugs; 2003; 63(21):2324. PubMed ID: 14524734
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral fludarabine: a viewpoint by David Oscier.
    Oscier D
    Drugs; 2003; 63(21):2324-5. PubMed ID: 14524735
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral fludarabine.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(21):2317-23. PubMed ID: 14524733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemia.
    Spaner DE
    Leukemia; 2012 May; 26(5):1144-5. PubMed ID: 22064354
    [No Abstract]   [Full Text] [Related]  

  • 6. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
    Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine for chronic lymphocytic leukemia.
    Proctor SJ; Mounter P; Summerfield GP
    N Engl J Med; 2001 Apr; 344(15):1167; author reply 1167-8. PubMed ID: 11302143
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludarabine for chronic lymphocytic leukemia.
    Copur MS; Ledakis P; Muhvic J
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial.
    Dearden CE; Richards S; Else M; Catovsky D; Hillmen P
    Cancer; 2011 Jun; 117(11):2452-60. PubMed ID: 24048793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia.
    Shustik C; Turner AR; Desjardins P; Fernandez L; Rubin S; Larratt L; Duncan AM; Rizi D; Sadura A; Shepherd L; Li D; Rassenti L; Kipps T
    Leukemia; 2010 Jan; 24(1):237-9. PubMed ID: 19812607
    [No Abstract]   [Full Text] [Related]  

  • 12. Fludarabine approved for use in chronic lymphocytic leukemia.
    Oncology (Williston Park); 1991 Jun; 5(6):20. PubMed ID: 1831638
    [No Abstract]   [Full Text] [Related]  

  • 13. Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study.
    Österborg A; Jewell RC; Padmanabhan-Iyer S; Kipps TJ; Mayer J; Stilgenbauer S; Williams CD; Hellmann A; Furman RR; Robak T; Hillmen P; Trnêný M; Dyer MJ; Piotrowska M; Kozak T; Gupta IV; Phillips JL; Goldstein N; Struemper H; Losic N; Lisby S; Wierda WG;
    Haematologica; 2015 Aug; 100(8):e311-4. PubMed ID: 25769539
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation.
    Cheson BD
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):14-21. PubMed ID: 9685175
    [No Abstract]   [Full Text] [Related]  

  • 15. Fludarabine in chronic lymphocytic leukemia and other hematological malignancies: progress in treatment. Fludarabine supplement.
    Binet JL
    Hematol J; 2004; 5 Suppl 1():S1. PubMed ID: 15079147
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral fludarabine therapy in chronic lymphocytic leukemia--increased convenience.
    Boogaerts MA
    Hematol J; 2004; 5 Suppl 1():S31-7. PubMed ID: 15079151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C; Coiffier B
    Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
    [No Abstract]   [Full Text] [Related]  

  • 18. Fludarabine for chronic lymphocytic leukemia.
    Erman M; Celik I; Tekuzman G
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete remission after fludarabine for chronic lymphocytic leukemia.
    Johnson SA; Richardson D; Hopkins J; Howe D; Phillips MJ
    Blood; 1993 Jan; 81(2):560. PubMed ID: 8422473
    [No Abstract]   [Full Text] [Related]  

  • 20. Response criteria with fludarabine therapy in chronic lymphocytic leukemia.
    Rai KR
    Blood; 1994 Feb; 83(3):875-6. PubMed ID: 8298148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.